OpenEvidence
PrivateLast Round
Growth Equity
Jul 19, 2026
Est. Valuation
$20B
Total Funding Raised
$985M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
OpenEvidence is a healthcare technology company that develops an AI-powered medical search engine and clinical decision support platform for healthcare professionals.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Clinical Trials, Drug Discovery, NLP & Conversational AI
Business Model
B2B2C
Customer Profile
Data as a Service, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OpenEvidence Comparables
Compare OpenEvidence with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wolters Kluwer | 83% | |
| Internet Brands | 82% | |
| NoveList | 79% |
OpenEvidence Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jul 19, 2026 | ||||
| Series D | Jan 21, 2026 | ||||
| Series C | Oct 20, 2025 | ||||
| Series B | Jul 15, 2025 | ||||
| Series A | Feb 19, 2025 |
Secondary Market Activity
Bids, offers, and trades by month
| Operation | Date | Price | Size | Share Class | Structure |
|---|---|---|---|---|---|
OFFER | |||||
BID |
Key People
Founding team and executive leadership
OpenEvidence Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series E |
| Breyer Capital | Series D |
| DST Global | Series D |
| Blackstone | Series C, Series D |
| ICONIQ Capital | Series D |
| GV | Series D, Series C, Series B |
| Conviction | Series B, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2026
$250M round led by Andreessen Horowitz and Byers Capital.
- Jul 19, 2026
$200M raised at $20B post-money valuation.
Recent news
Latest coverage and updates
- is_developingOct 14, 2026
On Oct 13th '26, OpenEvidence Inc. and Johns Hopkins Medicine announce a strategic collaboration to develop AI-enabled medical education approaches and clinical systems that help physicians apply current medical evidence to individual patients.
- is_developingOct 14, 2026
OpenEvidence Inc. and Johns Hopkins plan to design novel adaptive AI systems that prepare physicians to lead and continuously learn in an AI-native environment as part of a new medical education model.
- is_developingOct 14, 2026
OpenEvidence Inc. partners with Johns Hopkins Medicine to develop AI tools for physician training and clinical care, focusing on medical reasoning and patient safety, on Oct 14th '26.
- integrates_withOct 13, 2026
OpenEvidence Inc. integrates with Northwestern Medicine group
- launchesOct 5, 2026
OpenEvidence Inc. and Anthropic launch medical AI in 100 countries
OpenEvidence Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessAppears On
Curated lists and screens where this company is featured.
Frequently Asked Questions
Common questions about OpenEvidence's valuation, stock price, and market status.
Is OpenEvidence a public or private company?
OpenEvidence is a private company.
What is the current stock price of OpenEvidence?
OpenEvidence is a private company, so its shares have no public market price. Caplight tracks OpenEvidence's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OpenEvidence worth (valuation)?
OpenEvidence's valuation is estimated at $20.0B based on funding round data.
Can I buy OpenEvidence stock?
OpenEvidence shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OpenEvidence's last funding round?
OpenEvidence's most recent funding round was Growth Equity on July 19, 2026.
Who are the main investors in OpenEvidence?
Key investors in OpenEvidence include Andreessen Horowitz, DST Global, GV, Thrive Capital, Byers Capital.
Will OpenEvidence IPO soon?
No public IPO plans have been announced for OpenEvidence.
How can I track OpenEvidence secondary market activity?
Caplight tracks bids, offers, and trades in OpenEvidence's shares on secondary markets.